Dual-receptor-targeted nanomedicines: emerging trends and advances in lung cancer therapeutics - Supplementary figures
Cancer is the leading cause of mortality worldwide. Among all cancer types, lung cancer is recognized as
the most lethal and highly metastatic. The application of targeted nanomedicine loaded with anticancer
drugs is highly desirable for successful lung cancer treatment. However, due to the heterogenicity and
complexity of lung cancer, the therapeutic effectiveness of a single receptor targeting nanomedicine is
unfortunately limited. Therefore, the concept of dual-receptor-targeted nanomedicine is an emerging
trend for the advancement in lung cancer therapeutics. In this review, the authors discuss various
single- and dual-receptor-targeted nanomedicines that have been developed for lung cancer treatment.
Furthermore, the authors also discussed all the types of receptors that can be utilized in combination for
the development of dual-receptor-targeted nanomedicines.